Login / Signup

An NGS based MRD evaluation from acute myeloid leukemia patients.

Bin ChenLingling WangZhe WangHong ZhangLong ChenLei ZhangJing LiXiaoyan YanMiaoqing ZhaoYani LinKun Ru
Published in: International journal of laboratory hematology (2023)
The "AML NGS-MRD hot-spot panel" detected the mutations from relapsed AML patients with minimal panel size, and was a reliable and cost-effective panel for AML patients.
Keyphrases
  • acute myeloid leukemia
  • ejection fraction
  • newly diagnosed
  • prognostic factors
  • patient reported outcomes